Related Experiment Videos
CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study
D P van Kammen1, A Guidotti, T Neylan
1Western Psychiatric Institute and Clinic, University of Pittsburgh, School of Medicine, PA.
Abstract:
CSF diazepam-binding inhibitor-like immunoreactivity (DBI-LI) and polysomnography were studied in 28 drug-free male schizophrenic (DSM-III-R) patients. They underwent a three-night polysomnography evaluation and a lumbar puncture. CSF DBI-LI correlated positively with REM latency, the REM latency/2d nonREM period ratio and stage-4% sleep, and negatively with stage-1% sleep. CSF DBI-LI did not correlate significantly with duration of sleep or sleep latency. CSF DBI-LI during haloperidol treatment did not correlate significantly with sleep EEG measures. The results of this first study of the relationship between endogenous DBI and sleep in humans suggest that physiological effects of DBI other than interactions with the BZD/GABAA receptor complex may explain its positive effects on sleep. However, the absence of similar sleep data in normal subjects precludes us from establishing a specific relationship between DBI and sleep in schizophrenia.
Insights
Cerebrospinal fluid diazepam-binding inhibitor-like immunoreactivity (DBI-LI) in schizophrenia patients correlated with specific sleep patterns, suggesting non-benzodiazepine receptor effects may influence sleep. Further research is needed to confirm these findings in normal subjects.
Area of Science:
- Neuroscience
- Psychiatry
- Sleep Medicine
Background:
- Diazepam-binding inhibitor-like immunoreactivity (DBI-LI) is an endogenous peptide with potential roles in neurotransmission.
- Schizophrenia is often associated with sleep disturbances, but the underlying neurobiological mechanisms remain unclear.
Purpose of the Study:
- To investigate the relationship between cerebrospinal fluid (CSF) DBI-LI levels and polysomnographic sleep measures in drug-free male patients with schizophrenia.
- To explore potential correlations between DBI-LI and sleep parameters, including REM latency and sleep stages.
Main Methods:
- 28 drug-free male schizophrenic patients underwent a three-night polysomnography evaluation.
- Cerebrospinal fluid (CSF) was collected via lumbar puncture to measure DBI-LI.
- Correlations between CSF DBI-LI and various sleep parameters were analyzed.
Main Results:
- CSF DBI-LI showed positive correlations with REM latency, the REM latency/2d nonREM period ratio, and stage-4% sleep.
- A negative correlation was observed between CSF DBI-LI and stage-1% sleep.
- No significant correlations were found between CSF DBI-LI and sleep duration or sleep latency.
Conclusions:
- Endogenous DBI may exert physiological effects on sleep beyond its interaction with the BZD/GABAA receptor complex.
- The findings suggest a potential role for DBI in regulating specific sleep architecture features in schizophrenia.
- Further studies including normal subjects are necessary to establish a definitive link between DBI and sleep disturbances in schizophrenia.